Jubilant Ingrevia Limited (BOM:543271)

India flag India · Delayed Price · Currency is INR
629.70
-30.10 (-4.56%)
At close: Feb 14, 2025
29.25%
Market Cap 107.40B
Revenue (ttm) 42.01B
Net Income (ttm) 2.06B
Shares Out n/a
EPS (ttm) 13.05
PE Ratio 52.04
Forward PE n/a
Dividend 5.00 (0.79%)
Ex-Dividend Date Feb 3, 2025
Volume 11,068
Average Volume 22,088
Open 659.80
Previous Close 659.80
Day's Range 616.25 - 660.00
52-Week Range 422.00 - 884.95
Beta n/a
RSI 45.80
Earnings Date Jan 28, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal... [Read more]

Industry Chemicals and Allied Products
Founded 2019
Employees 2,283
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543271
Full Company Profile

Financial Performance

In 2023, Jubilant Ingrevia's revenue was 41.36 billion, a decrease of -13.34% compared to the previous year's 47.73 billion. Earnings were 1.83 billion, a decrease of -40.52%.

Financial Statements

News

There is no news available yet.